Logo image of BNOR.OL

BLUENORD ASA (BNOR.OL) Stock Fundamental Analysis

OSL:BNOR - Euronext Oslo - NO0010379266 - Common Stock - Currency: NOK

586  +4 (+0.69%)

Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to BNOR. BNOR was compared to 59 industry peers in the Oil, Gas & Consumable Fuels industry. There are concerns on the financial health of BNOR while its profitability can be described as average. BNOR is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

BNOR had negative earnings in the past year.
In the past year BNOR had a positive cash flow from operations.
In multiple years BNOR reported negative net income over the last 5 years.
Each year in the past 5 years BNOR had a positive operating cash flow.
BNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFBNOR.OL Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M

1.2 Ratios

The Return On Assets of BNOR (-1.36%) is worse than 83.05% of its industry peers.
With a Return On Equity value of -6.44%, BNOR is not doing good in the industry: 88.14% of the companies in the same industry are doing better.
Looking at the Return On Invested Capital, with a value of 5.00%, BNOR is doing worse than 67.80% of the companies in the same industry.
BNOR had an Average Return On Invested Capital over the past 3 years of 9.38%. This is significantly below the industry average of 14.75%.
The last Return On Invested Capital (5.00%) for BNOR is well below the 3 year average (9.38%), which needs to be investigated, but indicates that BNOR had better years and this may not be a problem.
Industry RankSector Rank
ROA -1.36%
ROE -6.44%
ROIC 5%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
BNOR.OL Yearly ROA, ROE, ROICBNOR.OL Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200 -200 400

1.3 Margins

BNOR has a Operating Margin of 27.70%. This is in the better half of the industry: BNOR outperforms 66.10% of its industry peers.
BNOR's Operating Margin has improved in the last couple of years.
With a decent Gross Margin value of 55.08%, BNOR is doing good in the industry, outperforming 62.71% of the companies in the same industry.
BNOR's Gross Margin has improved in the last couple of years.
Industry RankSector Rank
OM 27.7%
PM (TTM) N/A
GM 55.08%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
BNOR.OL Yearly Profit, Operating, Gross MarginsBNOR.OL Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2K -2K 4K -4K

2

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so BNOR is still creating some value.
Compared to 1 year ago, BNOR has more shares outstanding
BNOR has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, BNOR has a worse debt to assets ratio.
BNOR.OL Yearly Shares OutstandingBNOR.OL Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M 20M 25M
BNOR.OL Yearly Total Debt VS Total AssetsBNOR.OL Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

BNOR has a debt to FCF ratio of 13.72. This is a negative value and a sign of low solvency as BNOR would need 13.72 years to pay back of all of its debts.
BNOR has a Debt to FCF ratio of 13.72. This is comparable to the rest of the industry: BNOR outperforms 40.68% of its industry peers.
A Debt/Equity ratio of 1.53 is on the high side and indicates that BNOR has dependencies on debt financing.
With a Debt to Equity ratio value of 1.53, BNOR is not doing good in the industry: 86.44% of the companies in the same industry are doing better.
Industry RankSector Rank
Debt/Equity 1.53
Debt/FCF 13.72
Altman-Z N/A
ROIC/WACC0.57
WACC8.83%
BNOR.OL Yearly LT Debt VS Equity VS FCFBNOR.OL Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.20 indicates that BNOR should not have too much problems paying its short term obligations.
BNOR's Current ratio of 1.20 is on the low side compared to the rest of the industry. BNOR is outperformed by 71.19% of its industry peers.
BNOR has a Quick Ratio of 1.07. This is a normal value and indicates that BNOR is financially healthy and should not expect problems in meeting its short term obligations.
With a Quick ratio value of 1.07, BNOR perfoms like the industry average, outperforming 44.07% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.2
Quick Ratio 1.07
BNOR.OL Yearly Current Assets VS Current LiabilitesBNOR.OL Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M

5

3. Growth

3.1 Past

BNOR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -298.18%.
Looking at the last year, BNOR shows a decrease in Revenue. The Revenue has decreased by -5.10% in the last year.
Measured over the past years, BNOR shows a quite strong growth in Revenue. The Revenue has been growing by 16.10% on average per year.
EPS 1Y (TTM)-298.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
Revenue 1Y (TTM)-5.1%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%1.54%

3.2 Future

BNOR is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 68.13% yearly.
The Revenue is expected to grow by 20.10% on average over the next years. This is a very strong growth
EPS Next Y402.84%
EPS Next 2Y123.96%
EPS Next 3Y68.13%
EPS Next 5YN/A
Revenue Next Year80.41%
Revenue Next 2Y35.27%
Revenue Next 3Y20.1%
Revenue Next 5YN/A

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
BNOR.OL Yearly Revenue VS EstimatesBNOR.OL Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 200M 400M 600M 800M 1B
BNOR.OL Yearly EPS VS EstimatesBNOR.OL Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 -100 -200 -300

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BNOR. In the last year negative earnings were reported.
Based on the Price/Forward Earnings ratio of 6.88, the valuation of BNOR can be described as very cheap.
Based on the Price/Forward Earnings ratio, BNOR is valued a bit cheaper than 74.58% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 22.13. BNOR is valued rather cheaply when compared to this.
Industry RankSector Rank
PE N/A
Fwd PE 6.88
BNOR.OL Price Earnings VS Forward Price EarningsBNOR.OL Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 -10 20 -20

4.2 Price Multiples

Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of BNOR indicates a slightly more expensive valuation: BNOR is more expensive than 66.10% of the companies listed in the same industry.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of BNOR is on the same level as its industry peers.
Industry RankSector Rank
P/FCF 15.26
EV/EBITDA 7.2
BNOR.OL Per share dataBNOR.OL EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 100 200

4.3 Compensation for Growth

BNOR's low PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a rather cheap valuation of the company.
BNOR's earnings are expected to grow with 68.13% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y123.96%
EPS Next 3Y68.13%

0

5. Dividend

5.1 Amount

BNOR does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

BLUENORD ASA

OSL:BNOR (5/28/2025, 7:00:00 PM)

586

+4 (+0.69%)

Chartmill FA Rating
GICS SectorEnergy
GICS IndustryGroupEnergy
GICS IndustryOil, Gas & Consumable Fuels
Earnings (Last)05-14 2025-05-14/bmo
Earnings (Next)07-10 2025-07-10
Inst Owners35.59%
Inst Owner ChangeN/A
Ins Owners1.02%
Ins Owner ChangeN/A
Market Cap15.53B
Analysts82.86
Price Target761.77 (29.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-243.6%
Min EPS beat(2)-415.9%
Max EPS beat(2)-71.31%
EPS beat(4)0
Avg EPS beat(4)-163.08%
Min EPS beat(4)-415.9%
Max EPS beat(4)-48.1%
EPS beat(8)1
Avg EPS beat(8)-100.79%
EPS beat(12)3
Avg EPS beat(12)-92.95%
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-21.2%
Min Revenue beat(2)-33.43%
Max Revenue beat(2)-8.97%
Revenue beat(4)1
Avg Revenue beat(4)-12.39%
Min Revenue beat(4)-33.43%
Max Revenue beat(4)4.82%
Revenue beat(8)3
Avg Revenue beat(8)-4.3%
Revenue beat(12)5
Avg Revenue beat(12)-2.67%
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.25%
PT rev (3m)2.03%
EPS NQ rev (1m)-5.01%
EPS NQ rev (3m)-13.29%
EPS NY rev (1m)0%
EPS NY rev (3m)-10.27%
Revenue NQ rev (1m)-9%
Revenue NQ rev (3m)-15.53%
Revenue NY rev (1m)0.91%
Revenue NY rev (3m)-5.94%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 6.88
P/S 2.17
P/FCF 15.26
P/OCF 5.34
P/B 2.07
P/tB 2.57
EV/EBITDA 7.2
EPS(TTM)-22.14
EYN/A
EPS(NY)85.16
Fwd EY14.53%
FCF(TTM)38.4
FCFY6.55%
OCF(TTM)109.81
OCFY18.74%
SpS270.21
BVpS283.17
TBVpS228.36
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -1.36%
ROE -6.44%
ROCE 6.5%
ROIC 5%
ROICexc 5.8%
ROICexgc 6.14%
OM 27.7%
PM (TTM) N/A
GM 55.08%
FCFM 14.21%
ROA(3y)0.08%
ROA(5y)-0.18%
ROE(3y)-0.58%
ROE(5y)-1.96%
ROIC(3y)9.38%
ROIC(5y)6.79%
ROICexc(3y)10.23%
ROICexc(5y)7.37%
ROICexgc(3y)10.87%
ROICexgc(5y)7.85%
ROCE(3y)12.19%
ROCE(5y)8.82%
ROICexcg growth 3Y15.21%
ROICexcg growth 5Y43.84%
ROICexc growth 3Y15.53%
ROICexc growth 5Y45.83%
OM growth 3Y7.98%
OM growth 5Y29.98%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y5.05%
GM growth 5Y2.78%
F-Score3
Asset Turnover0.2
Health
Industry RankSector Rank
Debt/Equity 1.53
Debt/FCF 13.72
Debt/EBITDA 3.28
Cap/Depr 123.87%
Cap/Sales 26.43%
Interest Coverage 1.4
Cash Conversion 82.88%
Profit Quality N/A
Current Ratio 1.2
Quick Ratio 1.07
Altman-Z N/A
F-Score3
WACC8.83%
ROIC/WACC0.57
Cap/Depr(3y)220.14%
Cap/Depr(5y)197.46%
Cap/Sales(3y)32.67%
Cap/Sales(5y)36.08%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-298.18%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%300%
EPS Next Y402.84%
EPS Next 2Y123.96%
EPS Next 3Y68.13%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.1%
Revenue growth 3Y7.52%
Revenue growth 5Y16.1%
Sales Q2Q%1.54%
Revenue Next Year80.41%
Revenue Next 2Y35.27%
Revenue Next 3Y20.1%
Revenue Next 5YN/A
EBIT growth 1Y-30.7%
EBIT growth 3Y16.1%
EBIT growth 5Y50.9%
EBIT Next Year255.42%
EBIT Next 3Y53.78%
EBIT Next 5YN/A
FCF growth 1Y-73.6%
FCF growth 3YN/A
FCF growth 5Y-14.92%
OCF growth 1Y-54.57%
OCF growth 3Y84.65%
OCF growth 5Y4.46%